Texas invests $50M in psychedelic drug research to treat addiction
Medical Xpress
JUNE 16, 2025
The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. But experts say the risks can be lowered through heart screenings, close monitoring and giving magnesium before and during treatment, The Times added in its report. The process could take years.
52 
Let's personalize your content